YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Friday, Aug. 14, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Matthew RileyChairman and Chief Executive Officer - Lishan AklogChief Financial Officer - Dennis McGrath Nee…
PAVmed Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Portfolio Optimization Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick.…
[Business Person Reviewing Quarterly Report During Meeting in Office Setting] The second full week of August features a diverse earnings slate spanning AI infrastructure, semiconductors, space technology, healthcare, financials, and consum…
Image source: The Motley Fool. Date Monday, March 30, 2026 at 5:30 a.m. ET Call participants Chairman and Chief Executive Officer — Dr. Lishan Aklog Chief Financial Officer — Dennis McGrath Need a quote from a Motley Fool analyst? Email pr…
Major earnings expected before the bell on Friday include: * Sachem Capital Corp. (SACH [https://seekingalpha.com/symbol/SACH]) * Mizuho Financial Group (MFG [https://seekingalpha.com/symbol/MFG]) * Datavault AI (DVLT [https://seekingalpha…
Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago. These figures are adjusted for non-recurring items. This qu…
[Rolled newspaper with the headline Quarterly Results] Zerbor As earnings season enters another busy stretch, the upcoming week will bring a diverse mix of reports spanning AI infrastructure, semiconductors, e-commerce, clean energy, crypt…
Mettler-Toledo (MTD) came out with quarterly earnings of $8.91 per share, beating the Zacks Consensus Estimate of $8.7 per share. This compares to earnings of $8.19 per share a year ago. These figures are adjusted for non-recurring items.…
Alphatec (ATEC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items. This quarte…
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to a loss of $0.45 per share a year ago. These figures are adjusted for non-recu…
PAVmed Inc. PAVM recently announced the appointment of medical technology veteran Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices. In this role, he will lead the development and commercialization of the…
PAVmed Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Operational Drivers The company successfully finalized a multi-step recapitalization in February 2026, removing legacy toxic convertible securities to establish…
Major earnings expected before the bell on Monday include: * Fermi (FRMI [https://seekingalpha.com/symbol/FRMI]) * Sigma Lithium Corporation (SGML [https://seekingalpha.com/symbol/SGML]) * Rezolve AI PLC (RZLV [https://seekingalpha.com/sym…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Boxlight Corp. 84,993,859 2.53 2.02 2.18 +0.93 Smart Logistics Global Ltd.…
* PAVmed (PAVM [https://seekingalpha.com/symbol/PAVM]) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time. * The reverse stock split is intended to bring the company in…
(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key movers. BioAtla Inc. (BCAB) shares surged…
Shareholders of Leggett & Platt, Inc. (Symbol: LEG) looking to boost their income beyond the stock's 2.1% annualized dividend yield can sell the November covered call at the $10 strike and collect the premium based on the 60 cents bid, whi…
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a…
Newly-formed PAVmed subsidiary to license endoscopic imaging technology designed to identify and facilitate ablative treatment of esophageal dysplasia Lucid Diagnostics to collaborate with PAVmed as a strategic and equity partner on the te…
Introduction & Market Context PAVmed Inc. (NASDAQ:PAVM) presented its Q2 2025 business update on August 14, highlighting significant cost reduction measures and progress across its subsidiaries. The medical technology company, currently tr…
Major earnings expected before the bell on Thursday include: * JD.com (JD [https://seekingalpha.com/symbol/JD]) * Deere & Company (DE [https://seekingalpha.com/symbol/DE]) * First Majestic Silver Corp. (AG [https://seekingalpha.com/symbol/…
* PAVmed (NASDAQ:PAVM [https://seekingalpha.com/symbol/PAVM]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open. * The consensus EPS Estimate is -$0.25 [https://seekingalpha.com/symbol/PAVM/earnings/…
Major earnings expected before the bell on Wednesday include: * Tencent Holdings Limited (OTCPK:TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Stratasys Ltd. (SSYS [https://seekingalpha.com/symbol/SSYS]) * Organigram Global (OGI [https:/…
NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that…
NEW YORK - PAVmed Inc. (NASDAQ:PAVM), a commercial-stage medical technology company with a market capitalization of $10.17 million, announced Wednesday it has received a 180-day extension from Nasdaq to regain compliance with the $1.00 min…
* PAVmed (NASDAQ:PAVM [https://seekingalpha.com/symbol/PAVM]) has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under the Nasdaq listing rule. * The company now has until January 19, 202…
Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, July 30, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary o…
[Immunotherapy: A New Frontier in Cancer Detection and Treatment] bymuratdeniz Cancer test maker Lucid Diagnostics (NASDAQ:LUCD [https://seekingalpha.com/symbol/LUCD]), majority owned by PavMed (NASDAQ:PAVM [https://seekingalpha.com/symbol…
Virtual public CAC meeting to be held September 4, 2025, at 2:00 p.m. ET NEW YORK, July 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics co…
There are penny stocks and then are penny stock picks that are so outrageously wild that they should never be considered unless one is gambling with pocket change. And by pocket change, I’m talking almost literally. You’ve heard the expres…
Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, July 31, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical…
Conference Call and Webcast at 8:30AM Eastern Time NEW YORK, July 31, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and majority-owne…
NEW YORK, July 26, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ),…
Advocated stronger transparency and predictability, and inclusion of diagnostics, in federal proposals to improve equitable access to innovative lifesaving technologies Highlighted EsoGuard's life-saving potential, and unprecedented early…
NEW YORK, June 28, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, tod…
Dr. Lishan Aklog, PAVmed CEO, to participate in Fireside Chat with Maxim's Anthony Vendetti on Wednesday, June 21, 2023, at 1:30 PM ET. NEW YORK, June 14, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"),…